Medicenna Therapeutics Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $19,663,000.
Profit Margin
| 2015 | 0 | -833.49K | |
|---|---|---|---|
| 2016 | 0 | -1.33M | |
| 2018 | 0 | -7.46M | |
| 2019 | 0 | -4.70M | |
| 2021 | 0 | -17.18M | |
| 2022 | 0 | -22.64M | |
| 2024 | 0 | -25.46M |
MDNA.TO Income Statement (2014 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 5K | 38K | 40K | 6.81K | 9.70K | 1.43K | 0 |
Gross profit | -5K | -38K | -40K | -6.81K | -9.70K | -1.43K | 0 |
Operating exp. | |||||||
Research and development | 11.78M | 14.71M | 10.87M | 3.01M | 5.09M | 771.40K | 766.29K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 19.66M | 22.47M | 17.39M | 4.72M | 7.42M | 1.19M | 833.31K |
Operating income | -19.66M | -22.3M | -17.18M | -4.72M | -7.42M | -1.19M | -829.10K |
Other income (expenses), net | -5.80M | -277K | 106K | 19.15K | 4.97M | 1.33M | 185.91K |
Income before tax | -25.46M | -22.57M | -17.28M | -4.70M | -7.46M | -1.33M | -833.49K |
Income tax expense | 0 | 69K | -106K | 19.25K | 40.62K | 441 | 0 |
Net income | -25.46M | -22.64M | -17.18M | -4.70M | -7.46M | -1.33M | -833.49K |
Earnings per share | |||||||
Basic EPS | -0.37 | -0.42 | -0.35 | -0.18 | -0.31 | -0.08 | -0.05 |
Diluted EPS | -0.37 | -0.42 | -0.35 | -0.18 | -0.31 | -0.08 | -0.05 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |